Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Mitchell Report Highlights Increase in Electric Vehicle Collision Claims
Both the US and Canada see Q1 2023 rise in repairable claims frequency SAN DIEGO, Calif.—Mitchell, an Enlyte company and le
Business Insurance
In the News
Comp claims tangled by pot laws
Workers' Comp
News Release
Enlyte Named to CIO 100 Award List
Designation places company among the elite IT programs in the world CIO magazine
WorkCompWire
Article
Navigating the OnBoard Era: Streamlining Treatment Delivery in New York State
In the spring of 2022, the New York State Workers’ Compensation Board (WCB) rolled out OnBoard: Limited Release, transitioning key utilization revi
Workers' Comp
Article
Ask The Pharmacist: Exploring Drug Market Exclusivity and Generic Availability
When do drugs become generic? When drugs are first introduced, they are made available as brand name only for differing lengths of time d
Workers' Comp
Article
Medical Considerations for Referral to Field Case Management
Knowing when a claim could benefit from a referral to field case management can be complicated.